Overview
Open spinal dysraphism (OSD), also known as spina bifida aperta, is a group of congenital neural tube defects in which the spinal cord and/or its surrounding membranes are exposed through a defect in the vertebral arches and overlying skin. The most common forms include myelomeningocele (where the spinal cord and meninges protrude through the vertebral defect) and myelocele (where the neural placode is exposed at the skin surface). These defects occur during the first month of embryonic development when the neural tube fails to close properly. The condition primarily affects the nervous system, musculoskeletal system, and urogenital system. Key clinical features include motor and sensory deficits below the level of the lesion, lower limb weakness or paralysis, bowel and bladder dysfunction (neurogenic bladder and bowel), and orthopedic deformities such as clubfoot and hip dysplasia. Hydrocephalus is a frequent associated finding, occurring in approximately 80-90% of patients with myelomeningocele, often in association with Chiari II malformation. The severity of symptoms depends largely on the level and extent of the spinal defect, with higher (more cranial) lesions generally causing more extensive neurological impairment. Patients may experience loss of sensation, chronic pain, skin breakdown, and recurrent urinary tract infections. Tethered spinal cord can develop over time, leading to progressive neurological deterioration. Cognitive function is variable but can be affected, particularly when hydrocephalus is present. Treatment is multidisciplinary and typically begins with surgical closure of the defect within the first 24-48 hours of life to prevent infection and further neurological damage. Prenatal surgical repair (fetal surgery) has emerged as an option that may improve outcomes, as demonstrated by the MOMS (Management of Myelomeningocele Study) trial. Hydrocephalus is managed with ventriculoperitoneal shunting or endoscopic third ventriculostomy. Ongoing management includes urological care, orthopedic interventions, physical and occupational therapy, and neurosurgical surveillance. Folic acid supplementation before and during early pregnancy has been shown to significantly reduce the risk of neural tube defects. While there is no cure, comprehensive lifelong care can substantially improve quality of life and functional outcomes.
Also known as:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Open spinal dysraphism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Open spinal dysraphism at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Open spinal dysraphism.
Community
No community posts yet. Be the first to share your experience with Open spinal dysraphism.
Start the conversation →Latest news about Open spinal dysraphism
No recent news articles for Open spinal dysraphism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Open spinal dysraphism
What is Open spinal dysraphism?
Open spinal dysraphism (OSD), also known as spina bifida aperta, is a group of congenital neural tube defects in which the spinal cord and/or its surrounding membranes are exposed through a defect in the vertebral arches and overlying skin. The most common forms include myelomeningocele (where the spinal cord and meninges protrude through the vertebral defect) and myelocele (where the neural placode is exposed at the skin surface). These defects occur during the first month of embryonic development when the neural tube fails to close properly. The condition primarily affects the nervous system
How is Open spinal dysraphism inherited?
Open spinal dysraphism follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Open spinal dysraphism typically begin?
Typical onset of Open spinal dysraphism is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Open spinal dysraphism?
21 specialists and care centers treating Open spinal dysraphism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.